Ethionamide Alters Thyroid Receptor Gene Expression in Rats' Muscle

Ronny Lesmana, Setiawan Setiawan, Ferdyan Efza, Yuni Susanti Pratiwi, Gilang Muhamad Nur Iqbal, Hanna Goenawan, Nova Sylviana, Unang Supratman

Abstract


BACKGROUND: Ethionamide usage as one of the drug regimens still becomes a challenge due to high numbers of patients developing hypothyroid. Ethionamide had been associated with the inhibition of thyroid hormone (TH) synthesis and interestingly, ethionamide (C8H10N2S)-induced hypothyroidism is supported by its similar structure with thioamides, propythiouracil (C7H8N2S). However, hypothyroidism is not solely caused by its production, it could be caused by signaling alteration. Therefore, knowing that important TH action is determined via genomic pathway, alteration of this receptor could bring serious clinical problem. Unfortunately, there is limited study about the regulation of ethionamide and its connection on TH genomic signaling especially thyroid hormone receptor (TR) gene expression in soleus, gastrocnemius and cardiac muscle.

METHODS: Thirty-eight rats were divided into control, ethionamide and propylthiouracyl groups. After 12-week treatment, rat were sacrificed, then gastrocnemius, soleus and cardiac muscles were dissected out, snap freezed using liquid nitrogen, and stored in -80oC until use. RNA was extracted and run for reverse transcription polymerase chain reaction (RT-PCR).

RESULTS: In soleus muscle, ethionamide stimulated TR mRNA expressions and deiodinase compared to control group. In contrast, TRα1 gene expression was not affected by ethionamide administration. In gastrocnemius muscle, only TRβ1 gene and Dio2 gene expressions that were significantly increased compared to control group. In cardiac muscle, ethionamide significantly stimulated all the thyroid hormone receptor isoform and iodothyronine deiodinase gene expression compared to the control group.

CONCLUSION: Long ethionamide treatment upregulates TR gene expressions and deiodinase in soleus and cardiac muscle, there is different expression pattern of soleus, gastrocnemius and cardiac muscle after ethionamide stimulation.

KEYWORDS: ethionamide, hypothyroid, TRα1, TRα2, TRβ1, TRβ2


Full Text:

PDF

References


Hallbauer UM, Schaaf HS. Ethionamide-induced hypothyroidism in children. South Afr J Epidemiol Infect. 2011; 26: 161-3, CrossRef.

Thee S, Garcia-Prats AJ, Donald PR, Hesseling AC, Schaaf HS. A review of the use of ethionamide and prothionamide in childhood tuberculosis. Tuberculosis. 2016; 97: 126-36, CrossRef.

Yang TW, Park HO, Jang HN, Yang JH, Kim SH, Moon SH, et al. Side effects associated with the treatment of multidrug-resistant tuberculosis at a tuberculosis referral hospital in South Korea. Medicine. 2017; 96: e7482, CrossRef.

Thee S, Zöllner EW, Willemse M, Hesseling AC, Magdorf K, Schaaf HS. Abnormal thyroid function tests in children on ethionamide treatment. Int J Tuberc Lung Dis. 2011; 15: 1191-3, CrossRef.

Joseph P, Desai VBR, Mohan NS, Fredrick JS, Ramachandran R, Raman B, et al. Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India. Indian J Med Res. 2011; 133: 529-34, PMID.

Modongo C, Zetola NM. Prevalence of hypothyroidism among MDR-TB patients in Botswana. Int J Tuberc Lung Dis. 2012. 16: 1561-2, CrossRef.

Mallela AR, Koya R, Nagari SK, Mohapatra AK. Ethionamide: Unusual cause of hypothyroidism. J Clin Diagn Res. 2015; 9: OD08-9, CrossRef.

Braverman LE, Cooper DS, Kopp PA, Ingbar SH. Werner & Ingbar's The Thyroid : A Fundamental and Clinical Text. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2013, NLMID.

Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev. 2010; 31: 139-70, CrossRef.

Oetting A, Yen PM. New insights into thyroid hormone action. Best Pract Res Clin Endocrinol Metab. 2007; 21: 193-208, CrossRef.

Sperling M. Pediatric Endocrinology. 4th Edition. Philadelphia: Saunders; 2014, NLMID.

McDonnell ME, Braverman LE, Bernardo J. Hypothyroidism due to ethionamide. N Engl J Med. 2005; 352: 2757-9, CrossRef.

Baquedano MS, Ciaccio M, Dujovne N, Herzovich V, Longueira Y, Warman DM, et al. Two novel mutations of the TSH-beta subunit gene underlying congenital central hypothyroidism undetectable in neonatal TSH screening. J Clin Endocrinol Metab. 2010; 95: E98-103, CrossRef.

Ortiga-Carvalho TM, Chiamolera MI, Pazos-Moura CC, Wondisford FE. Hypothalamus-pituitary-thyroid axis. Compr Physiol. 2016; 6: 1387-428, CrossRef.

Lefebvre P, Benomar Y, Staels B. Retinoid X receptors: common heterodimerization partners with distinct functions. Trends Endocrinol Metab. 2010; 21: 676-83, CrossRef.

Calsolaro V, Niccolai F, Pasqualetti G, Calabrese AM, Polini A, Okoye C, et al. Overt and subclinical hypothyroidism in the elderly: when to treat? Front Endocrinol. 2019; 10: 177, CrossRef.

Brent GA. Mechanisms of thyroid hormone action. J Clin Invest. 2012; 122: 3035-43, CrossRef.

Yen PM, Darling DS, Chin WW. Basal and thyroid hormone receptor auxiliary protein-enhanced binding of thyroid hormone receptor isoforms to native thyroid hormone response elements. Endocrinology. 1991; 129: 3331-6, CrossRef.

Simonides WS, van Hardeveld C. Thyroid hormone as a determinant of metabolic and contractile phenotype of skeletal muscle. Thyroid. 2008; 18(2): 205-16, CrossRef.

Solanes G, Pedraza N, Calvo V, Vidal-Puig A, Lowell Bb, Villarroya F. Thyroid hormones directly activate the expression of the human and mouse uncoupling protein-3 genes through a thyroid response element in the proximal promoter region. Biochem J. 2005; 386: 505-13, CrossRef.

Zorzano A, Palacin M, Guma A. Mechanisms regulating GLUT4 glucose transporter expression and glucose transport in skeletal muscle. Acta Physiol Scand. 2005; 183: 43-58, CrossRef.

Dillmann W. Cardiac hypertrophy and thyroid hormone signaling. Heart Fail Rev. 2010; 15: 125-32, CrossRef.

Kahaly GJ, Dillmann WHJER. Thyroid hormone action in the heart. Endocr Rev. 2005; 26: 704-28, CrossRef.

Yen PM, Ando S, Feng X, Liu Y, Maruvada P, Xia X. Thyroid hormone action at the cellular, genomic and target gene levels. Mol Cell Endocrinol. 2006; 246: 121-7, CrossRef.

Kuzman J, Gerdes A, Kobayashi S, Liang Q. Thyroid hormone activates Akt and prevents serum starvation-induced cell death in neonatal rat cardiomyocytes. J Mol Cell Cardiol. 2005; 39: 841-4, CrossRef.

Kenessey A, Ojamaa K. Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. J Biol Chem. 2006; 281: 20666-72, CrossRef.

Ito K, Kagaya Y, Shimokawa H. Thyroid hormone and chronically unloaded hearts. Vascul Pharmacol. 2010; 52: 138-41, CrossRef.

Stammers AN, Susser SE, Hamm NC, Hlynsky MW, Kimber DE, Kehler DS, et al. The regulation of sarco (endo) plasmic reticulum calcium-ATPases (SERCA). Can J Physiol Pharm. 2015; 93: 843-54, CrossRef.

Davis PJ, Leonard JL, Davis FB. Mechanisms of nongenomic actions of thyroid hormone. Front Neuroendocrinol. 2008; 29: 211-8, CrossRef.

Grais IM, Sowers JR. Thyroid and the heart. Am J Med. 2014; 127: 691-8, CrossRef.

Lesmana R, Iwasaki T, Iizuka Y, Amano I, Shimokawa N, Koibuchi N. The change in thyroid hormone signaling by altered training intensity in male rat skeletal muscle. Endocr J. 2016; 63: 727-38, CrossRef.

Schapira M, Raaka BM, Das S, Fan L, Totrov M, Zhou Z, et al. Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking. Proc Natl Acad Sci USA. 2003; 100: 7354-9, CrossRef.

Miyazaki W, Iwasaki T, Takeshita A, Kuroda Y, Koibuchi N. Polychlorinated biphenyls suppress thyroid hormone receptor-mediated transcription through a novel mechanism. J Biol Chem. 2004; 279: 18195-202, CrossRef.

Machado DS, Sabet A, Santiago LA, Sidhaye AR, Chiamolera MI, Ortiga-Carvalho TM, et al. A thyroid hormone receptor mutation that dissociates thyroid hormone regulation of gene expression in vivo. Proc Natl Acad Sci USA. 2009; 106: p. 9441-6, CrossRef.

Estivalet AAF, Leiria LB, Dora JM, Rheinheimer J, Bouças AP, Maia AL, et al. D2 Thr92Ala and PPARgamma2 Pro12Ala polymorphisms interact in the modulation of insulin resistance in type 2 diabetic patients. Obesity. 2011; 19: 825-32, CrossRef.

Mentuccia D, Thomas MJ, Coppotelli G, Reinhart LJ, Mitchell BD, Shuldiner AR, et al. The Thr92Ala deiodinase type 2 (DIO2) variant is not associated with type 2 diabetes or indices of insulin resistance in the old order of Amish. Thyroid. 2005; 15: 1223-7, CrossRef.




DOI: https://doi.org/10.18585/inabj.v12i3.1138

Indexed by:

                 

                  

               

     

 

The Prodia Education and Research Institute